Trimethoprim-Sulfamethoxazole Compared with Vancomycin for the Treatment of Staphylococcus aureus Infection
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To compare trimethoprim-sulfamethoxazole (TMP-SMZ) and vancomycin regarding efficacy and safety in the therapy of serious Staphylococcus aureus infections. DESIGN: Randomized, double-blind comparative trial. SETTING: A tertiary-care hospital. PATIENTS: One hundred and one intravenous drug users hospitalized with S. aureus infection. MEASUREMENTS: Cure and failure rates; blood and wound cultures; minimum inhibitory and bactericidal concentrations; serum inhibitory and bactericidal titers; temperature; leukocyte count; durations of treatment and hospitalization; and toxicity. RESULTS: Of 228 intravenous drug users, 101 had S. aureus infection and were included in the efficacy analysis (43 received TMP-SMZ and 58 received vancomycin). Methicillin-resistant S. aureus (MRSA) accounted for 47% of S. aureus isolates, and 65% of patients were bacteremic. Infections were cured in 57 of 58 vancomycin recipients and in 37 of 43 TMP-SMZ recipients (P less than 0.02). Failure occurred mostly in patients with tricuspid valve endocarditis and only in those with infection caused by methicillin-sensitive S. aureus (MSSA). The mean duration of bacteremia was 6.7 days in TMP-SMZ recipients and 4.3 days in vancomycin recipients. Among 222 subjects hospitalized for at least 24 hours, toxicity rates were similar for TMP-SMZ (23%) and vancomycin (20%) recipients; nausea and vomiting were associated with TMP-SMZ and inflammation at the intravenous site was associated with vancomycin. Forty-four percent of TMP-SMZ recipients and 29% of vancomycin recipients experienced side effects in the efficacy cohort (P greater than 0.05). CONCLUSIONS: Vancomycin is superior to TMP-SMZ in efficacy and safety when treating intravenous drug users who have staphylococcal infections. However, all treatment failures occurred in patients with MSSA infection at any site. Therefore, TMP-SMZ may be considered as an alternative to vancomycin in selected cases of MRSA infection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, all treatment failures with trimethoprim-sulfamethoxazole occurred in patients infected with MSSA in that report, 165 whereas patients with MRSA infection were uniformly cured.”
In the citing paper
“Although Markowitz et al 165 showed that trimethoprimsulfamethoxazole was inferior to vancomycin in the treatment of invasive S aureus infections, it is sometimes used in salvage situations.”
Citations
Cites
Levine, D. P., Fromm, B. S., & Reddy, B. R. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-9-674 · Cited by 577 · cited 2×
“Clinical correlates of these observations may only be evident in high-inoculum infections such as endocarditis, which may explain the prolonged period of bacteremia and the high TMP-SMZ failure rate found in our study (47, 49).”
BackgroundBarrett, F. F., McGehee, R. F., & Finland, M. (1968) · New England Journal of Medicine · doi:10.1056/nejm196808292790901 · Cited by 512 · cited 1×
“Although the initial reports of methicillin-resistant Staphylococcus aureus (MRSA) in the United States appeared in 1960, a hospital outbreak did not occur until the latter part of the decade (1, 2).”
BackgroundRetrospective study of the toxicity of preparations of vancomycin from 1974 to 1981
Farber, B. F., & Moellering, R. C. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.23.1.138 · Cited by 432
HALEY, R. W., HIGHTOWER, A. W., KHABBAZ, R. F., THORNSBERRY, C., MARTONE, W. J., ALLEN, J. R., & HUGHES, J. M. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-3-297 · Cited by 404 · cited 2×
“By the mid-tolate 1970s, many more reports of MRSA in the United States appeared, leading to its recognition as an important nosocomial pathogen (3).”
BackgroundVancomycin for Staphylococcus aureus endocarditis in intravenous drug users
Small, P. M., & Chambers, H. F. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.6.1227 · Cited by 399 · cited 1×
“Clinical correlates of these observations may only be evident in high-inoculum infections such as endocarditis, which may explain the prolonged period of bacteremia and the high TMP-SMZ failure rate found in our study (47, 49).”
BackgroundMethicillin-Resistant Staphylococcus aureus: Introduction and Spread Within a Hospital
PEACOCK, J. E., MARSIK, F. J., & WENZEL, R. P. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-4-526 · Cited by 391 · cited 1×
“is not supported by other clinical investigations (41-45).”
ResultCrossley, K., Loesch, D., Landesman, B., Mead, K., Chern, M., & Strate, R. (1979) · Journal of Infectious Diseases · doi:10.1093/infdis/139.3.273 · Cited by 390
SARAVOLATZ, L. D., MARKOWITZ, N., ARKING, L., POHLOD, D., & FISHER, E. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-1-11 · Cited by 355 · cited 1×
“In 1980, this organism emerged among Detroit-area parenteral drug users in a community-acquired epidemic (4).”
BackgroundSelf-citationKORZENIOWSKI, O., & SANDE, M. A. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-4-496 · Cited by 355 · cited 1×
“6 days reported by Korzeniowski and coworkers (46) in 13 nafcillin-treated drug users with tricuspid valve endocarditis (46).”
BackgroundManual of Clinical Microbiology
HARE, J. D. (1975) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.1975.02120430086036 · Cited by 323
Research works printed but not linked: 8
- Pugsley D, 1969, Postgrad Med J., 45, 95
- Bernstein-Hahn L, 1969, Paraplegia., 7, 96
- Bernstein-Hahn L, 1971, Int Surg., 46, 8
- Rosaschino F, 1973, Trimethoprim/sulphamethoxazole in Bacterial Infections. An International Symposium in Sardinia, April 26-27, 1972., 165
- Goodwin N, 1973, S Air Med J., 47, 2159
- Muangman V, 1973, J Med Assoc Thailand., 56, 448
- Bajpai J, 1977, Int Surg., 62, 172
- 10.1001/jama.1983.03330440050032 · doi:10.1001/jama.1983.03330440050032
Cited by
Mandell, L. A., Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean, N. C., Dowell, S. F., File, T. M., Musher, D. M., Niederman, M. S., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/511159 · Cited by 6,202
“Previous experience with TMP-SMX in other types of severe infections (endocarditis and septic thrombophlebitis) suggests that TMP-SMX is inferior to vancomycin [239].”
BackgroundTong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
“staphylococcal infections, such as bacteremia and endocarditis [90].”
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
David, M. Z., & Daum, R. S. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00081-09 · Cited by 1,972
Metadata
- Authors
- Markowitz, N., Quinn, E. L., & Saravolatz, L. D.
- Affiliations
- Henry Ford Hospital (US)
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1992-09-01
- Volume
- 117
- Issue
- 5
- Pages
- 390-398
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2043567648
- Semantic Scholar
- 63fe8afb165f133b5d21b70186fbe72b4ecfc6a7
- Cited by
- 343
- References
- 57
- Citations by year
- 2024: 9 · 2023: 4 · 2022: 4 · 2021: 2 · 2020: 6 · 2019: 2 · 2018: 9 · 2017: 9 · 2016: 5 · 2015: 16 · 2014: 16 · 2013: 5 · 2012: 12
- FWCI
- 5.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Keywords
- trimethoprim-sulfamethoxazole, vancomycin, Staphylococcus aureus infection, methicillin-resistant Staphylococcus aureus, methicillin-susceptible Staphylococcus aureus, people who inject drugs, bacteremia, tricuspid valve endocarditis, antibiotic efficacy, drug toxicity, duration of bacteremia
- MeSH terms
- Adult, Bacteriophage Typing, Double-Blind Method, Female, Humans, Male, Microbial Sensitivity Tests, Prospective Studies, Staphylococcal Infections, Vancomycin, Trimethoprim, Sulfamethoxazole Drug Combination, Substance Abuse, Intravenous, Methicillin Resistance, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Trimethoprim-Sulfamethoxazole Compared with Vancomycin for the Treatment of Staphylococcus aureus Infection. https://app.cochat.ai/papers/10.7326/0003-4819-117-5-390
- The paper
- Markowitz, N., Quinn, E. L., & Saravolatz, L. D. (1992). Trimethoprim-Sulfamethoxazole Compared with Vancomycin for the Treatment of Staphylococcus aureus Infection. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-117-5-390
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.